Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Celltrion Merger Swap Event: Trading Dynamics Post-Merger Approval

Celltrion Inc/Healthcare Merger. Pharm Is Next

Celltrion Merger Swap: Conditions & Schedule

Quiddity Advisors

Event-Driven

<ul>
<li>Back on the 17 August, biopharmaceuticals developer and producer <strong><a href="https://www.smartkarma.com/entities/celltrion-inc" target="_blank" data-smartkarma-citation="entities:991:1" rel="noopener">Celltrion Inc (068270 KS)</a></strong> announced a merger with <strong><a href="https://www.smartkarma.com/entities/celltrion-healthcare-co-ltd" target="_blank" data-smartkarma-citation="entities:23641:1" rel="noopener">Celltrion Healthcare (091990 KS)</a></strong>.</li>
<li>On October 23rd, shareholders approved the merger. The appraisal rights exercise period commenced on the 23 October and ends on November 13. 28th December is the merger's effective date.</li>
<li>Initially, the stock purchase rights limit was set at 1₩tn; however Celltrion Group's founder/Chairman Seo Jung-jin has removed this limit. That takes care of NPS, which opposes the merger.</li>
</ul>


Back on the 17 August, biopharmaceuticals developer and producer Celltrion Inc (068270 KS) announced a merger with Celltrion Healthcare (091990 KS).
On October 23rd, shareholders approved the merger. The appraisal rights exercise period commenced on the 23 October and ends on November 13. 28th December is the merger's effective date.
Initially, the stock purchase rights limit was set at 1₩tn; however Celltrion Group's founder/Chairman Seo Jung-jin has removed this limit. That takes care of NPS, which opposes the merger.


Celltrion Healthcare

Celltrion Merger Update: Limits Lifted